Skip to main content
Chad Weldy, MD, Cardiology, Stanford, CA, Stanford Health Care

ChadWeldyMD PhD

Cardiology • Stanford, CA

Cardiologist, Physician-Scientist, Stanford Center for Inherited Cardiovascular Disease, Instructor of Medicine

Join to view full profile

Dr. Weldy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Weldy's full profile

Already have an account?

Summary

  • Dr. Chad Weldy is a cardiologist and a faculty member (Instructor) within the Division of Cardiovascular Medicine and the Stanford Center for Inherited Cardiovascular Disease. He received his M.D. from Duke University School of Medicine and completed his internal medicine internship, residency, and cardiology fellowship at Stanford University as a member of the Stanford Translational Investigator Program (TIP) where he conducted research within the lab of Dr. Thomas Quertermous focused on epigenetics, RNA editing, and genetic mechanisms of disease. Prior to entering medical school, he received his Ph.D. from the University of Washington and completed a postdoctoral fellowship with the University of Washington, Division of Cardiology where he conducted basic science research investigations within the fields of cardiovascular biology, redox biology, toxicology, and epigenetics. Dr. Weldy has a clinical expertise within the field of inherited cardiomyopathies where he treats patients and families within Stanford’s Center for Inherited Cardiovascular Disease (SCICD). As a physician-scientist, Dr. Weldy works to better understand human genetics, epigenetics, and transcriptional regulation in cardiovascular disease. Dr. Weldy has received funding through an NIH/NHLBI K08 Clinical Scientist Research Career Development Award, an American Heart Association Career Development Award (CDA), an F32 Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship award, and an NIH Loan Repayment Award on his work focused on the genetic, epigenetic, and RNA editing mechanisms of vascular disease. Within Stanford, Dr. Weldy has been the recipient of the Gerald Reaven Award for Basic Science from the Division of Cardiovascular Medicine, he has been inducted into AOA from the Stanford School of Medicine, and he was the recipient for the Timothy F. Beckett Jr. Award for Best Clinical Teaching from the Department of Medicine.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2019 - 2023
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2018 - 2019
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 2017 - 2018
  • Duke University School of Medicine
    Duke University School of MedicineClass of 2017
  • University of Washington School of Medicine
    University of Washington School of MedicinePost-Doctoral Fellowship, Cardiovascular Pathology, 2012 - 2014
  • University of Washington
    University of WashingtonPhD, Toxicology, 2007 - 2012

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2018 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • K08 Mentored Clinician Scientist Career Development Award NIH/NHLBI, 2023
  • AHA Career Development Award American Heart Association, 2023
  • Timothy F. Beckett Jr. Award for Best Clinical Teaching by a Medicine Fellow Stanford University School of Medicine, 2021
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Wegovy’s Heart Benefits Due to More Than Weight Loss, Novo Says
    Wegovy’s Heart Benefits Due to More Than Weight Loss, Novo SaysNovember 13th, 2023
  • FDA Gives Nod to Novo Nordisk’s Wegovy for Reducing Heart Risks
    FDA Gives Nod to Novo Nordisk’s Wegovy for Reducing Heart RisksMarch 12th, 2024
  • US Obesity Doctors Expect Weight-Loss Drug Lilly to Have Similar Cardiac Benefit to Wegovy
    US Obesity Doctors Expect Weight-Loss Drug Lilly to Have Similar Cardiac Benefit to WegovyDecember 4th, 2023
  • Join now to see all

Hospital Affiliations

Dr. Chad Weldy, Dr. Chad Weldy, MD, Dr. C Weldy